Qualitative Study About Psychedelics Using in Psychiatric Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-30

Study Completion Date

2025-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is set up to better understand the current use of psychedelics in France in the general population. The present focus on individuals who have used any type of psychedelic drug in order to suppress or alleviate a psychiatric symptom in the context of a diagnosed pathology. The data are collected during a semi-structured interview and then studied in a thematic analysis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin

NCT03604744

Healthy

COMPLETED EARLY_PHASE1

Comparative Acute Effects of LSD, Psilocybin and Mescaline

NCT04227756

Healthy

COMPLETED PHASE1

Persisting Effects of Psilocybin

NCT02971605

Healthy

COMPLETED PHASE1/PHASE2

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

NCT06624137

OCD Major Depressive Disorder (MDD) Alcohol Use Disorder (AUD) +8 more

RECRUITING

Personality Disorders and Substance Use Disorders in a Sexual Context in the Man Having Sex With Other Men Population

NCT03753737

Substance Use Disorders

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychiatric Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients using psychedelic substances

Adult patients self-administering psychedelic substances in psychiatric disorders

Interview

Intervention Type DIAGNOSTIC_TEST

An interview will be conducted to describe the experiences of people with psychiatric disorders who use psychedelic substances for therapeutic purposes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interview

An interview will be conducted to describe the experiences of people with psychiatric disorders who use psychedelic substances for therapeutic purposes

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with a psychiatric disorder by a psychiatrist or general practitioner
* Patients used psychedelic or related substances in order to treat psychiatric symptoms
* Patients have given their oral non-opposition
* Patients affiliated to a social security scheme